Health practices and vaginal microbicide acceptability among urban black women

Journal of Women's Health

Volumn 17, Issue 8, 2008, Pages 1345-1351

  Reiff, Marian ^a,c   Wade, Christine ^a   Chao, Maria T ^a   Kronenberg, Fredi ^a   Cushman, Linda F ^b  

^a Columbia University ^*  (United States)

^b Department of Medicine   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROBICIDE;

ADULT; AFRICAN AMERICAN; ARTICLE; BIRTH CONTROL; CULTURAL FACTOR; DECISION MAKING; DRUG SAFETY; FEMALE; HEALTH CARE; HEALTH EDUCATION; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; URBAN AREA; WOMEN'S HEALTH;

ADMINISTRATION, INTRAVAGINAL; ADULT; AFRICAN AMERICANS; ANALYSIS OF VARIANCE; ANTI-INFECTIVE AGENTS, LOCAL; CHOICE BEHAVIOR; COMPLEMENTARY THERAPIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; INTERVIEWS AS TOPIC; MIDDLE AGED; NEW YORK CITY; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES; URBAN POPULATION;

EID: 52749094886     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2008.0886     Document Type: Article

References (38)

1. Alliance for Microbicide Development. Microbicide Research and Development Database. Available at www.microbicide. org Accessed August 1, 2007.
2. Koo HP, Woodsong C, Dalberth BT, Viswanathan M, Simons-Rudolph A. Context of acceptability of topical microbicides: Sexual relationships. 2005;61:67-93.
3. Mantell JE, Myer L, Carballo-Dieguez A, et al. Microbicide acceptability research: current approaches and future directions. Soc Sci Med 2005;60:319-330.
4. Stein ZA. HIV prevention: The need for methods women can use. Am J Public Health 1990;80:460-462.
5. Severy LJ, Newcomer S. Critical issues in contraceptive and STI acceptability research. J Soc Issues 2005;61:45-65.
6. Elias C, Coggins C. Acceptability research on female-controlled barrier methods to prevent heterosexual transmission of HIV: Where have we been? Where are we going? J Womens Health Gend Based Med 2001;10:163-173.
7. Severy LJ, Tolley E, Woodsong C, Guest G. A framework for examining the sustained acceptability of microbicides. AIDS Behav 2005;9:121-131.
8. CDC. HIV/AIDS among women. 2007. Available at www.cdc.gov/hiv/topics/ women/resources/factsheets/women.htm Accessed July 1, 2007.
9. Kaiser Family Foundation. African Americans and HIV/AIDS. Available at www.kff.org/hivaids/upload/6089-04.pdf
10. Braunstein S, van de Wijgert J. Preferences and practices related to vaginal lubrication: Implications for microbicide acceptability and clinical testing. J Womens Health 2005;14:424-433.
11. Woodsong C. Covert use of topical microbicides: Implications for acceptability and use. Int Fam Plann Perspect 2004;30:94-98.
12. Martin Hilber A, Chersich MF, van de Wijgert JHHM, Rees H, Temmerman M. Vaginal practices, microbicides and HIV: What do we need to know? Sex Transm Infect 2007;83:505-508.
13. WHO. Multi-country study on gender, sexuality and vaginal practices. Available at www.who.int/reproductivehealth/fgm/harmfulpractices.htm Accessed April 14, 2008.
14. Martino JL, Youngpairoj S, Vermund SH. Vaginal douching: Personal practices and public policies. J Womens Health 2004;13:1048-1065.
15. CDC. Fertility, family planning and reproductive health of U.S. women-National survey of family growth. Vital and health statistics series, 23 number 25. Available at www.cdc.gov/nchs/data/series/sr_23/sr23_025.pdf Accessed August 1, 2007.
16. Snowden R, Christian B, eds. Patterns and perceptions of menstruation: A World Health Organization international collaborative study. New York: St. Martin's Press, 1983.
17. Hardy E, de Padua KS, Hebling EM, Osis MJ, Zaneveld LJ. Women's preferences for vaginal antimicrobial contraceptives. V: Attitudes of Brazilian women to the insertion of vaginal products. Contraception 2003;67:391-395.
18. Garro LC. On the rationality of decision-making studies: Part 1: Decision models of treatment choice. Med Anthropol Q 1998;12:319-340.
19. Hunt LM, Mattingly C. Diverse rationalities and multiple realities in illness and healing. Med Anthropol Q 1998;12:267-272.
20. Wade C, Chao M, Kronenberg F, Cushman L, Kalmuss D. Medical pluralism among American women: Results of a national survey. J Womens Health 2008;17:829-840.
21. Upchurch DM, Chyu L, Greendale GA, et al. Complementary and alternative medicine use among American women: Findings from the National Health Interview Survey, 2002. J Womens Health 2007;16:102-113.
22. National Institutes of Health/National Center for Complementary and Alternative Medicine website. Available at nccam.nih.gov/health/whatiscam/ #1 Accessed February 29, 2008.
23. Kronenberg F, Cushman LF, Wade CM, Kalmuss Dc, Chao MT. Race/ethnicity and women's use of complementary and alternative medicine in the United States: results of a national survey. (Erratum: Am J Public Health 2006;96:1340) Am J Public Health 2006;96:1236-1242.
24. Dessio W, Wade C, Chao M, Kronenberg F, Cushman LE, Kalmuss D. Religion, spirituality, and healthcare choices of African-American women: Results of a national survey. Ethnicity Dis 2004;14:189-197.
25. Bair YA, Gold EB, Greendale GA, et al. Ethnic differences in use of complementary and alternative medicine at midlife: Longitudinal results from SWAN participants. Am J Public Health 2002;92:1832-1840.
26. Factor-Litvak P, Cushman LF, Kronenberg F, Wade C, Kalmuss D. Use of complementary and alternative medicine among women in New York City: A pilot study. J Alternative Complementary Med 2001;7:659-666.
27. Ni H, Simile C, Hardy A. Utilization of complementary and alternative medicine by United States adults: Results from the 1999 National Health Interview Survey. Med Care 2002;40:353-358.
28. Graham R, Ahn A, Davis R, O'Connor B, Eisenberg D, Phillips R. Use of complementary and alternative medicine among ethnic minority adults in the United States: Results from the 2002 National Health Interview Survey. J Natl Med Assoc 2005;97:535-545.
29. Mackenzie E, Taylor L, Bloom B, Hufford D, JCJ. Ethnic minority use of complementary and alternative medicine (CAM): A national probability survey of CAM utilizers. Alternative Ther Health Med 2003;9:50-56.
30. Chao MT, Wade C, Kronenberg F, Kalmuss D, Cushman LF. Women's reasons for complementary and alternative medicine use: Racial/ethnic differences. J Alternative Complementary Med 2006;12:719-720.
31. Barnett MC, Cotroneo M, Purnell J, Martin D, Mackenzie E, Fishman A. Use of CAM in local African-American communities: Community-partnered research. J Natl Med Assoc 2003;95:943-950.
32. User's manual for ATLAS.ti 5.0. Version 5. Berlin: ATLAS.ti Scientific Software Development GmbH, 2004.
33. Pawluch D, Cain R, Gillet J. Lay constructions of HIV and complementary therapy use. Soc Sci Med 2000;51:251-264.
34. Joglekar NS, Joshi SN, Navlakha SN, Katti UR, Mehendale SM. Acceptability of Praneem polyherbal vaginal tablet among HIV uninfected women and their male partners in Pune, India - Phase I study. Indian J Med Res 2006;123:547-552.
35. Seth SD, Sharma B, Bano R, Ganguly NK. Microbicide development: New challenges. Indian J Med Res 2006;123:719-722.
36. Gupta G. Microbicidal spermicide or spermicidal microbicide? Eur J Contraception Reprod Health Care 2005;10:212-218.
37. Jones DL, Weiss SM, Malow R, et al. A brief sexual barrier intervention for women living with AIDS: Acceptability, use, and ethnicity. J Urban Health 2001;78:593-604.
38. Minnis AM, Shiboski SC, Padian NS. Barrier contraceptive method acceptability and choice are not reliable indicators of use. Sex Transm Dis 2003;30:556-561.